Toxic effect of xylazine, self-harm, initial encounter

This code describes the adverse health effects resulting from a deliberate overdose or self-poisoning with xylazine. Xylazine is a veterinary sedative and analgesic that can cause severe central nervous system depression, respiratory depression, and cardiovascular effects in humans. The "initial encounter" signifies that the patient is receiving active treatment for the acute effects of the poisoning.

This code is appropriate for documenting cases where a patient presents to a healthcare facility with symptoms of xylazine toxicity and admits to or is suspected of intentionally self-administering the substance. This includes emergency department visits, inpatient admissions, or initial outpatient evaluations for acute management of the overdose. It should be used when the primary reason for the encounter is the treatment of the toxic effects.

• Always confirm the intent as "intentional self-harm" through documentation; if accidental, a different intent code is required.
• Ensure the encounter is truly the "initial encounter" for this specific poisoning event; subsequent care would use a different encounter character.
• Code all manifestations of the xylazine toxicity, such as respiratory failure or cardiac arrhythmias, in addition to this primary code.